Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Observational Study of ORALAIR® (Grass Pollen Allergen Extract From: Cocksfoot, Sweet Vernal, Rye Grass, Meadow Grass, Timothy) Tablet for Sublingual Use in Children 5 to 9 Years of Age With Grass-pollen-induced Allergic Rhinitis With or Without Conjunctivitis

NCT02295969 is registered in ClinicalTrials.gov with Stallergenes Greer as lead sponsor.

NCT NCT02295969
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02295969 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Observational Study of ORALAIR® (Grass Pollen Allergen Extract From: Cocksfoot, Sweet Vernal, Rye Grass, Meadow Grass, Timothy) Tablet for Sublingual Use in Children 5 to 9 Years of Age With Grass-pollen-induced Allergic Rhinitis With or Without Conjunctivitis
Lead sponsor
Stallergenes Greer
Phase
Observational
Overall status
Completed
Start date
December 31, 2014
Completion date
July 3, 2017
Enrollment
307 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

allergy